Investigative Medicine Division
We aim to rapidly translate innovative science into patient benefit across a range of disease areas. From molecular biology and target discovery, through to interventional medicine and informing policy, we bring together researchers in a diverse range of specialties including acute stroke, dementia and immunology.
Head of Division
Latest publications
-
Lymphatic vessels in bone support regeneration after injury.
Journal article
Biswas L. et al, (2023), Cell, 186, 382 - 397.e24
-
Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2.
Journal article
Huang K-YA. et al, (2023), Nat Commun, 14
-
Intelectin-1 binds and alters the localization of the mucus barrier-modifying bacterium Akkermansia muciniphila.
Journal article
Matute JD. et al, (2023), J Exp Med, 220
-
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication.
Journal article
Moll T. et al, (2023), Life Sci Alliance, 6
-
Staphylococcal phosphatidylglycerol antigens activate human T cells via CD1a.
Journal article
Monnot GC. et al, (2022), Nat Immunol
COVID-19 research
Novel all-in-one vaccine developed to tackle future coronavirus threats
6 July 2022
Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.
Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
What's new
New study reveals role of lymphatic system in bone healing
19 January 2023
Bones were thought to lack lymphatic vessels, but new research from the Kusumbe Group published in Cell not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.
Anjali Kusumbe receives the RMS Life Sciences Medal
29 September 2022
The Royal Microscopical Society awards celebrate the best in microscopy, recognising those making a special contribution to microscopy, cytometry and imaging.
Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m
5 August 2022
Co-founded by Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.